Hepatocellular carcinoma in the very elderly: to treat or not to treat?

We report a case of a patient with hepatocellular carcinoma (HCC) who has two unusual features. The patient was 95 years old at the time of diagnosis and his excellent response to treatment. The authors briefly review the age distribution of HCC and the treatments used. We concluded that therapy sho...

Full description

Saved in:
Bibliographic Details
Published inMedical and pediatric oncology Vol. 22; no. 2; p. 84
Main Authors Arbaje, Y M, Carbone, P P
Format Journal Article
LanguageEnglish
Published United States 1994
Subjects
Aged
Aged, 80 and over
alpha-Fetoproteins - analysis
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Biomarkers, Tumor - analysis
Carcinoma, Hepatocellular - diagnosis
Carcinoma, Hepatocellular - drug therapy
Cisplatin - administration & dosage
Colonic Neoplasms
Humans
Interferon-alpha - administration & dosage
Liver Neoplasms - diagnosis
Liver Neoplasms - drug therapy
Male
Neoplasms, Second Primary
Patient Advocacy
Treatment Outcome
Online AccessGet more information

Cover

More Information
Summary:We report a case of a patient with hepatocellular carcinoma (HCC) who has two unusual features. The patient was 95 years old at the time of diagnosis and his excellent response to treatment. The authors briefly review the age distribution of HCC and the treatments used. We concluded that therapy should not be arbitrarily withheld based solely on chronological age. Older cancer patients deserve the right to be treated if they so wish.
ISSN:0098-1532
DOI:10.1002/mpo.2950220204